 |
市場調査レポート
商品コード
1561423
ペプチド治療薬市場レポート：タイプ別、メーカー別、合成技術別、投与経路別、用途別、地域別、2024年～2032年Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| ペプチド治療薬市場レポート：タイプ別、メーカー別、合成技術別、投与経路別、用途別、地域別、2024年～2032年 |
|
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
世界のペプチド治療薬市場の市場規模は2023年に428億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに869億米ドルに達し、2024年から2032年の間に7.9%の成長率（CAGR）を示すと予測しています。
ペプチドは、イオンチャネルやGタンパク質共役型受容体（GPCR）などの特定の細胞表面受容体に結合し、細胞内作用を引き起こす効率的かつ選択的なシグナル伝達分子です。製薬業界では、幅広い細胞を標的とし、その応答を操作できる新しい再生治療薬をデザインするために採用されています。これらの治療薬は、他の治療法よりも毒性が低く、比較的安全で、忍容性が高いです。その結果、がん、傷害、感染症、代謝異常、美容上の問題を管理するために、世界中の臨床現場で支持を集めています。
ペプチド治療薬市場傾向：
急性および慢性疾患の有病率の増加と医療施設へのアクセスの向上は、革新的な治療法を開発するためのペプチド需要にプラスの影響を与えている主要な要因の一つです。さらに、ペプチド治療は、皮膚の老化プロセスを遅らせるために美容外科手術に使用されています。このことは、個人の外見に対する意識の高まりや、若々しく健康な肌を保ちたいという願望と相まって、世界中で美容外科手術やペプチド治療薬の採用を後押ししています。これとは別に、注射回数を減らし、安定性やその他の物理的特性を改善する新規合成戦略のイントロダクションより、ペプチド治療薬は糖尿病患者への注射に広く使用されています。このことは、糖尿病の罹患率の増加や迅速かつ正確な治療法に対する嗜好の高まりと相まって、経口薬よりもペプチド治療薬の使用に影響を与えています。さらに、個別化治療や標的化治療の新たな動向が、多機能ペプチドベースの材料に対する需要を喚起しています。これに加えて、自己免疫疾患や炎症性疾患を治療するための新規ペプチド治療薬を開発するための資金が増加しており、市場の見通しは明るいと予測されます。
本レポートで扱う主な質問
- 世界のペプチド治療薬市場の市場規模は？
- 2024-2032年の世界のペプチド治療薬市場の予想成長率は？
- 世界のペプチド治療薬市場を牽引する主要因は何か？
- 世界のペプチド治療薬市場に対するCOVID-19の影響は？
- 世界のペプチド治療薬市場のタイプ別内訳は？
- 世界のペプチド治療薬市場のメーカータイプ別内訳は？
- 世界のペプチド治療薬市場の合成技術別の内訳は？
- 世界のペプチド治療薬市場の投与経路に基づく内訳は？
- 世界のペプチド治療薬市場の用途別内訳は？
- 世界のペプチド治療薬市場の主要地域は？
- 世界のペプチド治療薬市場における主要プレイヤー/企業は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界のペプチド治療薬市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：タイプ別
- イノベーティブ
- 市場動向
- 市場予測
- ジェネリック
- 市場動向
- 市場予測
第7章 市場内訳：メーカー別
- アウトソーシング
- 市場動向
- 市場予測
- 社内
- 市場動向
- 市場予測
第8章 市場内訳：合成技術別
- 固相ペプチド合成
- 市場動向
- 市場予測
- 液相ペプチド合成
- 市場動向
- 市場予測
- ハイブリッド技術
- 市場動向
- 市場予測
第9章 市場内訳：投与経路別
- 非経口
- 市場動向
- 市場予測
- 経口
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第10章 市場内訳：用途別
- 胃腸障害
- 市場動向
- 市場予測
- 神経疾患
- 市場動向
- 市場予測
- 代謝障害
- 市場動向
- 市場予測
- がん
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第11章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第12章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第13章 バリューチェーン分析
第14章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第15章 価格分析
第16章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Amgen Inc.
- Apitope International NV
- Arch Biopartners Inc.
- AstraZeneca plc
- Circle Pharma Inc.
- Corden Pharma GmbH
- F. Hoffmann-La Roche AG
- Ipsen Group
- Lonza Group AG
- Novo Nordisk A/S
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
- Zealand Pharma A/S
図表
List of Figures
- Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
- Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2023
- Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2023
- Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2023
- Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2023
- Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2023
- Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2023
- Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
- Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2023
- Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
- Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
- Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million US$), 2024-2032
- Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million US$), 2024-2032
- Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million US$), 2024-2032
- Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 8: Global: Peptide Therapeutics Market: Competitive Structure
- Table 9: Global: Peptide Therapeutics Market: Key Players
目次
Product Code: SR112024A4510
The global peptide therapeutics market size reached US$ 42.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 86.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.
Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.
Peptide Therapeutics Market Trends:
The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.
Breakup by Type:
- Innovative
- Generic
Breakup by Type of Manufacturer:
- Outsourced
- In-house
Breakup by Synthesis Technology:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Breakup by Routes of Administration:
- Parenteral
- Oral
- Others
Breakup by Application:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.
Key Questions Answered in This Report
- 1. How big is the global peptide therapeutics market?
- 2. What is the expected growth rate of the global peptide therapeutics market during 2024-2032?
- 3. What are the key factors driving the global peptide therapeutics market?
- 4. What has been the impact of COVID-19 on the global peptide therapeutics market?
- 5. What is the breakup of the global peptide therapeutics market based on the type?
- 6. What is the breakup of the global peptide therapeutics market based on the type of manufacturer?
- 7. What is the breakup of the global peptide therapeutics market based on the synthesis technology?
- 8. What is the breakup of the global peptide therapeutics market based on the routes of administration?
- 9. What is the breakup of the global peptide therapeutics market based on the application?
- 10. What are the key regions in the global peptide therapeutics market?
- 11. Who are the key players/companies in the global peptide therapeutics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Peptide Therapeutics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Innovative
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Type of Manufacturer
- 7.1 Outsourced
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 In-house
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Synthesis Technology
- 8.1 Solid Phase Peptide Synthesis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hybrid Technology
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Routes of Administration
- 9.1 Parenteral
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Oral
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Application
- 10.1 Gastrointestinal Disorders
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Neurological Disorders
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Metabolic Disorders
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Cancer
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
- 10.5 Others
- 10.5.1 Market Trends
- 10.5.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Amgen Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Apitope International NV
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.3 Arch Biopartners Inc.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.4 AstraZeneca plc
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.4.4 SWOT Analysis
- 16.3.5 Circle Pharma Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.6 Corden Pharma GmbH
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 F. Hoffmann-La Roche AG
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 SWOT Analysis
- 16.3.8 Ipsen Group
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 Lonza Group AG
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Novo Nordisk A/S
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Pfizer Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.12 Teva Pharmaceuticals Industries Ltd.
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.13 Zealand Pharma A/S
- 16.3.13.1 Company Overview
- 16.3.13.2 Product Portfolio
- 16.3.13.3 Financials
- 16.3.1 Amgen Inc.
